Underdog Pharmaceuticals
Dr. Clemens received his B.S. in biochemistry from the University of California, Los Angeles in 2004 and Ph.D. in biomedical sciences from the University of California, Irvine in 2013. He has participated in every aspect of the biology side of drug development, from in vitro screening through IND-enabling toxicology and pharmacology and regulatory filing. Dr. Clemens is the author on 11 peer-reviewed scientific articles and has authored the Investigator’s Brochure for an anticoagulant currently in clinical trials.
This person is not in any offices
Underdog Pharmaceuticals
Underdog develops interventions targeting toxic forms of cholesterol to provide true disease-modifying treatments for age-related diseases.